Photo: Depositphotos
Aug 8, 2025, 06:08
Better-Targeted Therapies for Patients with Acute Myeloid Leukemia – IU Simon Comprehensive Cancer Center
IU Simon Comprehensive Cancer Center shared a post on LinkedIn:
“A new discovery from IU Simon Comprehensive Cancer Center and Indiana University School of Medicine researchers could lead to more effective therapies for acute myeloid leukemia (AML), one of the most aggressive and fatal blood cancers in adults.
The team identified a previously unknown immune cell linked to AML progression. Because current treatments often lead to relapse or resistance, this finding could help create better-targeted therapies—and improve outcomes for patients.
AML starts in the bone marrow and interferes with blood cell formation. It’s currently the sixth-leading cause of cancer-related death in adults.”
More posts featuring Acute Myeloid Leukemia on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36
Aug 25, 2025, 16:04